Biselli R, Nisini R, Lista F, Autore A, Lastilla M, De Lorenzo G
Biomedicines. 2022; 10(8).
PMID: 36009598
PMC: 9405556.
DOI: 10.3390/biomedicines10082050.
Wu S, Zhang Z, Yu R, Zhang J, Liu Y, Song X
Clin Vaccine Immunol. 2013; 21(2):156-64.
PMID: 24307239
PMC: 3910935.
DOI: 10.1128/CVI.00560-13.
Dumas E, Nguyen M, Cox P, Rodgers H, Peterson J, James J
Vaccine. 2013; 31(14):1856-63.
PMID: 23415781
PMC: 3614092.
DOI: 10.1016/j.vaccine.2013.01.040.
Pomerantsev A, Pomerantseva O, Moayeri M, Fattah R, Tallant C, Leppla S
Protein Expr Purif. 2011; 80(1):80-90.
PMID: 21827967
PMC: 3183367.
DOI: 10.1016/j.pep.2011.05.016.
Dorea J
Neurochem Res. 2011; 36(6):927-38.
PMID: 21350943
DOI: 10.1007/s11064-011-0427-0.
Genetic vaccines for anthrax based on recombinant adeno-associated virus vectors.
Liu T, Oscherwitz J, Schnepp B, Jacobs J, Yu F, Cease K
Mol Ther. 2008; 17(2):373-9.
PMID: 19002162
PMC: 2835057.
DOI: 10.1038/mt.2008.242.
Genetic medicine strategies to protect against bioterrorism.
Boyer J, Crystal R
Trans Am Clin Climatol Assoc. 2008; 117:297-310.
PMID: 18528482
PMC: 1500914.
Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.
Hashimoto M, Boyer J, Hackett N, Wilson J, Crystal R
Infect Immun. 2005; 73(10):6885-91.
PMID: 16177368
PMC: 1230977.
DOI: 10.1128/IAI.73.10.6885-6891.2005.
Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
Williamson E, Hodgson I, Walker N, Topping A, Duchars M, Mott J
Infect Immun. 2005; 73(9):5978-87.
PMID: 16113318
PMC: 1231098.
DOI: 10.1128/IAI.73.9.5978-5987.2005.
Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.
Sawada-Hirai R, Jiang I, Wang F, Sun S, Nedellec R, Ruther P
J Immune Based Ther Vaccines. 2004; 2(1):5.
PMID: 15140257
PMC: 420254.
DOI: 10.1186/1476-8518-2-5.
Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures.
Puziss M, Manning L, Lynch J, BARCLAYE , ABELOW I, Wright G
Appl Microbiol. 1963; 11:330-4.
PMID: 13972634
PMC: 1057997.
DOI: 10.1128/am.11.4.330-334.1963.
Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine.
Schneerson R, Kubler-Kielb J, Liu T, Dai Z, Leppla S, Yergey A
Proc Natl Acad Sci U S A. 2003; 100(15):8945-50.
PMID: 12857944
PMC: 166418.
DOI: 10.1073/pnas.1633512100.
Development of an improved vaccine for anthrax.
Leppla S, Robbins J, Schneerson R, Shiloach J
J Clin Invest. 2002; 110(2):141-4.
PMID: 12122102
PMC: 151073.
DOI: 10.1172/JCI16204.
Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis.
Farchaus J, Ribot W, Jendrek S, Little S
Appl Environ Microbiol. 1998; 64(3):982-91.
PMID: 9501438
PMC: 106355.
DOI: 10.1128/AEM.64.3.982-991.1998.
Comparison of enzyme-linked immunosorbent and indirect hemagglutination assays for determining anthrax antibodies.
J Clin Microbiol. 1984; 20(3):357-61.
PMID: 6436303
PMC: 271329.
DOI: 10.1128/jcm.20.3.357-361.1984.
Agar diffusion method for the differentiation of Bacillus anthracis.
Angelety L, Wright G
Appl Microbiol. 1971; 21(1):157-9.
PMID: 4993230
PMC: 377139.
DOI: 10.1128/am.21.1.157-159.1971.
Immunological analysis of cell-associated antigens of Bacillus anthracis.
Ezzell Jr J, Abshire T
Infect Immun. 1988; 56(2):349-56.
PMID: 3123387
PMC: 259287.
DOI: 10.1128/iai.56.2.349-356.1988.
Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.
Little S, Knudson G
Infect Immun. 1986; 52(2):509-12.
PMID: 3084385
PMC: 261029.
DOI: 10.1128/iai.52.2.509-512.1986.
Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.
Turnbull P, Broster M, Carman J, Manchee R, Melling J
Infect Immun. 1986; 52(2):356-63.
PMID: 3084381
PMC: 261006.
DOI: 10.1128/iai.52.2.356-363.1986.
Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide.
Wright G, Mandell G
J Exp Med. 1986; 164(5):1700-9.
PMID: 3021891
PMC: 2188454.
DOI: 10.1084/jem.164.5.1700.